OKLAHOMA CITY–(BUSINESS WIRE)–#ClassAction–Federman & Sherwood announces that on June 3, 2019, a class action
lawsuit was filed in the United States District Court for the Southern
District of California against Heron Therapeutics, Inc. (NASDAQ: HRTX).
The complaint alleges violations of federal securities laws, Sections
10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5,
including allegations of issuing a series of material or false
misrepresentations to the market which had the effect of artificially
inflating the market price during the Class Period, which is October 31,
2018 through April 30, 2019.
To learn how to participate in this action, please visit https://www.federmanlaw.com/blog/federman-sherwood-announces-the-filing-of-a-securities-class-action-lawsuit-against-heron-therapeutics-inc/
Plaintiff seeks to recover damages on behalf of all Heron Therapeutics,
Inc. shareholders who purchased common stock during the Class Period and
are therefore a member of the Class as described above. You may move the
Court no later than Monday, August 5, 2019 to serve as a lead plaintiff
for the entire Class. However, in order to do so, you must meet certain
legal requirements pursuant to the Private Securities Litigation Reform
Act of 1995.
If you wish to discuss this action, obtain further information and
participate in this or any other securities litigation, or should you
have any questions or concerns regarding this notice or preservation of
your rights, please contact:
Robin Hester
FEDERMAN & SHERWOOD
10205 North Pennsylvania
Avenue
Oklahoma City, OK 73120
Email to: [email protected]
Or,
visit the firm’s website at www.federmanlaw.com
Contacts
Robin Hester
[email protected]
